mTOR inhibition in T-cell lymphoma: A path(way) forward Journal Article

  

Authors:	Moskowitz, A. J.; Horwitz, S. M.
Article Title:	mTOR inhibition in T-cell lymphoma: A path(way) forward
Abstract:	In this issue of Blood, Witzig et al report on the promising in vitro and in vivo activity of everolimus in T-cell lymphoma (TCL) and pave the way for future combination studies.1 © 2015 by The American Society of Hematology.
Keywords:	cancer survival; protein phosphorylation; prednisone; doxorubicin; note; cyclophosphamide; vincristine sulfate; t cell lymphoma; mammalian target of rapamycin; initiation factor 4e; negative feedback; mammalian target of rapamycin inhibitor; everolimus; romidepsin; rapamycin; pralatrexate; belinostat; brentuximab vedotin; human; priority journal
Journal Title:	Blood
Volume:	126
Issue:	3
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2015-07-16
Start Page:	284
End Page:	286
Language:	English
DOI:	10.1182/blood-2015-05-644724
PROVIDER:	scopus
PUBMED:	26185115
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-84937797977&partnerID=40&md5=118dc000b54b44a98d4088ff955fa2e5
Notes:	Export Date: 2 September 2015 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/79675